rs150646335

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_138459.5(NUS1):​c.506C>G​(p.Pro169Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,612,386 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 7 hom. )

Consequence

NUS1
NM_138459.5 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.83

Publications

1 publications found
Variant links:
Genes affected
NUS1 (HGNC:21042): (NUS1 dehydrodolichyl diphosphate synthase subunit) This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X. [provided by RefSeq, May 2017]
NUS1 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 55, with seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital disorder of glycosylation, type IAA
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008862853).
BP6
Variant 6-117693132-C-G is Benign according to our data. Variant chr6-117693132-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 569348.
BS2
High Homozygotes in GnomAdExome4 at 7 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUS1NM_138459.5 linkc.506C>G p.Pro169Arg missense_variant Exon 2 of 5 ENST00000368494.4 NP_612468.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUS1ENST00000368494.4 linkc.506C>G p.Pro169Arg missense_variant Exon 2 of 5 1 NM_138459.5 ENSP00000357480.3

Frequencies

GnomAD3 genomes
AF:
0.00112
AC:
170
AN:
151902
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00177
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00137
AC:
344
AN:
250502
AF XY:
0.00151
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.000843
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000924
Gnomad NFE exome
AF:
0.00238
Gnomad OTH exome
AF:
0.000655
GnomAD4 exome
AF:
0.00165
AC:
2410
AN:
1460366
Hom.:
7
Cov.:
29
AF XY:
0.00163
AC XY:
1184
AN XY:
726578
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33428
American (AMR)
AF:
0.00101
AC:
45
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39542
South Asian (SAS)
AF:
0.000720
AC:
62
AN:
86154
European-Finnish (FIN)
AF:
0.000992
AC:
53
AN:
53410
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5760
European-Non Finnish (NFE)
AF:
0.00194
AC:
2155
AN:
1111022
Other (OTH)
AF:
0.00139
AC:
84
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
117
234
351
468
585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00112
AC:
170
AN:
152020
Hom.:
0
Cov.:
32
AF XY:
0.00112
AC XY:
83
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41508
American (AMR)
AF:
0.00105
AC:
16
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00177
AC:
120
AN:
67900
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00174
Hom.:
0
Bravo
AF:
0.00131
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00175
AC:
15
ExAC
AF:
0.00155
AC:
188
EpiCase
AF:
0.00202
EpiControl
AF:
0.00202

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability, autosomal dominant 55, with seizures Uncertain:1
Oct 04, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].

NUS1-related disorder Benign:1
May 01, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Congenital disorder of glycosylation, type IAA Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NUS1: BP4, BS2

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
22
DANN
Benign
0.91
DEOGEN2
Benign
0.053
T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.057
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.0089
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.8
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.025
Sift
Benign
0.35
T
Sift4G
Benign
0.25
T
Vest4
0.23
ClinPred
0.017
T
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.082
gMVP
0.36
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150646335; hg19: chr6-118014295; COSMIC: COSV99055244; API